Literature DB >> 22249095

Caroli's syndrome in a post renal transplant patient: case report and review of the literature.

Muhammad Z Bawany1, Osama Alaradi, Ali Nawras.   

Abstract

Caroli's syndrome is characterized by bile duct ectasia in association with hepatic fibrosis. It is usually transmitted in an autosomal recessive fashion and has been well documented to be associated with autosomal recessive polycystic kidney disease and occasionally with autosomal dominant polycystic kidney disease. However, there has been only few case reports published with Caroli's syndrome diagnosed postrenal transplantation.

Entities:  

Mesh:

Year:  2012        PMID: 22249095      PMCID: PMC3271697          DOI: 10.4103/1319-3767.91728

Source DB:  PubMed          Journal:  Saudi J Gastroenterol        ISSN: 1319-3767            Impact factor:   2.485


Caroli's syndrome is characterized by bile duct ectasia in association with hepatic fibrosis.[12] Caroli's disease is a congenital disorder characterized by multifocal, segmental dilatation of large intrahepatic bile ducts. The condition is usually associated with renal cystic disease of varying severity. If it is only characterized by bile duct ectasia without apparent hepatic abnormalities then it is called Caroli's disease, as opposed to Caroli's syndrome in which there is hepatic fibrosis. It is usually transmitted in an autosomal recessive fashion and has been well documented to be associated with autosomal recessive polycystic kidney disease (ARPKD) and occasionally with autosomal dominant polycystic kidney disease (ADPKD).[3] However, there has been only few case reports published with Caroli's syndrome diagnosed postrenal transplantation.

CASE REPORT

We report a case of 52-year-old Caucasian male who was referred to us for the evaluation of elevated liver enzymes. His medical history was significant for renal transplantation 13 years ago outside our institution secondary to end-stage renal disease due to ADPKD. He had no history of smoking or alcohol use. At presentation, his vital signs were stable except for the temperature of 99 F. Rest of the physical examination was unremarkable. At his first presentation liver function tests (LFTs) showed albumin of 3.7 g/dl, bilirubin 1.7 mg/dl with direct bilirubin 0.6 mg/dl, alkaline phosphatase 188 IU/l, ALT 50 IU/l, and AST 40 IU/l. Patient's prior LFT's were normal. Ultrasound of the liver revealed dilated biliary tree with sludge in gallbladder. CT scan of abdomen revealed marked intrahepatic biliary dilatation [Figure 1] with common bile duct measuring 1 cm. Patient had ERCP, which showed dilatation and stricturing of the intrahepatic biliary tree and multiple stones within biliary tree that were removed after performing sphincterectomy.
Figure 1

CAT scan showing saccular dilatation of biliary tree mostly in the right lobe of the liver

CAT scan showing saccular dilatation of biliary tree mostly in the right lobe of the liver Subsequently, the patient presented to our institution with a complaint of repeated bouts of low-grade fever associated with right upper quadrant abdominal pain and mildly elevated liver enzymes. CT scan of abdomen revealed persistent biliary tree dilatation. ERCP revealed multiple saccular dilatations within the intrahepatic biliary tree (left more than right) [Figure 2]. Multiple balloon sweeps were performed; several stone fragments with sludge were removed. Patient continued to have recurrent cholangitis, therefore, he was eventually evaluated for liver transplant and finally received orthotopic liver from a deceased donor. Pathology of patient's native liver revealed cavernous biliary ectasia with broad bands of fibrosis consistent with Caroli's syndrome.
Figure 2

ERCP showing diffuse saccular dilatation of biliary tree (left>right)

ERCP showing diffuse saccular dilatation of biliary tree (left>right)

DISCUSSION

The molecular pathogenesis of Caroli's syndrome is incompletely understood. However, frequent association of Caroli's syndrome with ARPKD suggest role of fibrocystin (the protein encoded by the ARPKD gene PKHD1) in the pathogenesis.[4] Presentation of caroli's syndrome varies depending on the age of onset and type of inheritance. Caroli's syndrome can also lead to cirrhosis of the liver in some patients,[5] as opposed to our patient, who did not have signs of cirrhosis. To our knowledge, there are only five cases reported of Caroli's disease postsolid organ transplant in English literature,[6-10] all of the solid organ transplants were kidney transplant, just like in our patient. Review of these articles showed the primary cause of renal transplant was either ARPKD (three out of five) or ADPKD (two out of five) [Table 1].
Table 1

Caroli's syndrome in postsolid organ transplant

Caroli's syndrome in postsolid organ transplant Treatment is basically supportive and needs to be individualized. Conservative therapy with antibiotics might fail because of immunosuppressive state in post-transplantation patient, which was considered to be the cause of failure in three out of five patients reported with the history of renal transplantation. Surgery is an option for those who develop recurrent cholangitis. Liver transplantation is the treatment of choice for refractory cholangitis and diffuse involvement of liver,[11] like in our patient. However if the disease is localized in one segment or lobe of the liver, lobectomy then can be considered.[12]

CONCLUSION

Caroli's syndrome in a patient with a history of renal transplantation carries high risk of recurrent or refractory cholangitis due to immunosuppressive state, therefore, surgical therapy, i.e., liver transplantation, needs to be considered early in the course of treatment if the conservative therapy fails. Learning point: Although, there is enough literature about Caoli's syndrome in autosomal recessive polycystic kidney disease; there are only two reports of Caroli's syndrome in patients with autosomal dominant poycystic kidney disease diagnosed after renal transplantation.
  12 in total

1.  Caroli's disease of the liver in a renal transplant recipient.

Authors:  Vadakethu T Ninan; Mangalathillam R N Nampoory; Kaivilayil V Johny; Ram K Gupta; Imre Schmidt; Prasad M Nair; Jaber Al-Ali
Journal:  Nephrol Dial Transplant       Date:  2002-06       Impact factor: 5.992

Review 2.  Management of cystic disease of the liver.

Authors:  J E Doty; R K Tompkins
Journal:  Surg Clin North Am       Date:  1989-04       Impact factor: 2.741

3.  Renal transplantation in Caroli's disease.

Authors:  R Rault
Journal:  Clin Nephrol       Date:  2005-05       Impact factor: 0.975

Review 4.  Liver and kidney disease in ciliopathies.

Authors:  Meral Gunay-Aygun
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-11-15       Impact factor: 3.908

5.  Caroli's disease and autosomal dominant polycystic kidney disease: a rare association?

Authors:  C Mousson; M Rabec; J P Cercueil; J S Virot; P Hillon; G Rifle
Journal:  Nephrol Dial Transplant       Date:  1997-07       Impact factor: 5.992

6.  The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.

Authors:  Christopher J Ward; Marie C Hogan; Sandro Rossetti; Denise Walker; Tam Sneddon; Xiaofang Wang; Vicky Kubly; Julie M Cunningham; Robert Bacallao; Masahiko Ishibashi; Dawn S Milliner; Vicente E Torres; Peter C Harris
Journal:  Nat Genet       Date:  2002-02-04       Impact factor: 38.330

Review 7.  Diseases of the intrahepatic biliary tree.

Authors:  J Caroli
Journal:  Clin Gastroenterol       Date:  1973-01

Review 8.  Caroli's syndrome and adult polycystic kidney disease.

Authors:  Susan Shedda; Amanda Robertson
Journal:  ANZ J Surg       Date:  2007-04       Impact factor: 1.872

9.  Long-term outcome of liver resection and transplantation for Caroli disease and syndrome.

Authors:  Frank Ulrich; Johann Pratschke; Andreas Pascher; Ulf P Neumann; Enrique Lopez-Hänninen; Sven Jonas; Peter Neuhaus
Journal:  Ann Surg       Date:  2008-02       Impact factor: 12.969

Review 10.  An atypical course of Caroli's disease in a renal transplant patient--case report and review of the literature.

Authors:  S Abouchacra; S Toumeh; Y Boobes; B Bernieh; W Gorka
Journal:  Clin Nephrol       Date:  2004-04       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.